These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 667554)

  • 21. CDC's guidelines on infection control; more guidelines.
    Crow S
    Infect Control Urol Care; 1982; 7(1):27-42. PubMed ID: 6923853
    [No Abstract]   [Full Text] [Related]  

  • 22. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contamination of sterile fluids.
    Tallet ER
    Br Med J; 1978 Dec; 2(6152):1645. PubMed ID: 728769
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of an aseptic technique testing and challenge kit (ATTACK).
    Turco S; Miele WH; Barnoski D
    Hosp Pharm; 1993 Jan; 28(1):11-3, 16-8. PubMed ID: 10124004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Organization of a station for sterile solutions in a hospital pharmacy. The contribution of paramedical personnel to the small-scale production of perfusion preparations].
    Urseanu C; Kreiss M; Rotaru V; Anton A; Toma S; Enache Z; Jalcovschi L; Ionică L; Stanciu J
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1983 Oct; 31(10):227-30. PubMed ID: 6417886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience in preparing injection solutions in the pharmacy of a military hospital].
    Chirkov AI; Britvich NP
    Voen Med Zh; 1999 May; 320(5):73-4. PubMed ID: 10401256
    [No Abstract]   [Full Text] [Related]  

  • 27. Codes + standards. Pharmacy facts. Architectural and environmental changes required for USP 797.
    Bernstein WN
    Health Facil Manage; 2005 Jul; 18(7):39-40. PubMed ID: 16130375
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inactivation and removal of prions in producing medical products. A contribution to evaluation and declaration of possible methods].
    Bertram J; Mielke M; Beekes M; Lemmer K; Baier M; Pauli G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):36-40. PubMed ID: 15205822
    [No Abstract]   [Full Text] [Related]  

  • 29. Investors buying compounders. Drug shortages are persisting, leading to the deals.
    Lee J
    Mod Healthc; 2013 Jan; 43(3):12-3. PubMed ID: 23487975
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of the hospital pharmacist in the Infection Control Committee. Exemplified by the Bichat University Hospital Center].
    Dauphin A; Farinotti R
    Agressologie; 1987 Dec; 28(12):1205-9. PubMed ID: 3450198
    [No Abstract]   [Full Text] [Related]  

  • 31. Particulate matter determination in LVPs produced in Dutch hospital pharmacies, Part 1: Particle-counting accuracy.
    Van der Veen J; Verbrugge P; Van de Vaart FJ; Boom FA
    PDA J Pharm Sci Technol; 1997; 51(2):81-8. PubMed ID: 9146039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upgrading quality assurance for pharmacy-prepared sterile products.
    Zellmer WA
    Am J Hosp Pharm; 1991 Nov; 48(11):2387-8. PubMed ID: 1746571
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbial contamination of glass bottle (open-vented) and plastic bag (closed-nonvented) intravenous fluid delivery systems.
    Poretz DM; Guynn JB; Duma RJ; Dalton HP
    Am J Hosp Pharm; 1974 Aug; 31(8):726-32. PubMed ID: 4604770
    [No Abstract]   [Full Text] [Related]  

  • 35. ASHP invitational conference on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1991 Nov; 48(11):2391-7. PubMed ID: 1746572
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of evidence for ASHP's sterile-products guidelines.
    Kopcha RG
    Am J Health Syst Pharm; 2004 Jul; 61(14):1445-6. PubMed ID: 15332690
    [No Abstract]   [Full Text] [Related]  

  • 37. Recapping needles in the pharmacy.
    Green J
    Am J Health Syst Pharm; 1997 Feb; 54(3):258, 261. PubMed ID: 9028416
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidosage medication vials: a study of sterility, use patterns, and cost-effectiveness.
    de Silva MI; Hood E; Tisdel E; Mize GN
    Am J Infect Control; 1986 Jun; 14(3):135-8. PubMed ID: 3089069
    [No Abstract]   [Full Text] [Related]  

  • 39. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 40. Infection risks of multiple dose vials examined.
    Hosp Infect Control; 1981 Dec; 8(12):157-9. PubMed ID: 10253430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.